
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
7 Powerful Methods for forestalling Telephone Overheating: Keep Your Gadget Cool - 2
Tesla Germany Registrations Quadruple to 9,252 Vehicles in Best March Ever - 3
Dependable Savvy Locks to Update Your Home Security - 4
German Easter peace marches draw tens of thousands - 5
Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
Doctor's orders? ‘Belly laugh at least two to five days a week'
'The Real Housewives of Rhode Island' 1st teaser trailer unveiled: Which Bachelor Nation star is part of the cast? And when does it premiere?
Figure out How to Alter Your Volvo XC40 for Further developed Solace
How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'
This St Nick Truly Can Advise How To Drink And Hack Your Headache
Find the Insider facts of Compelling Systems administration: Building Associations for Progress
Clocks to go forward one hour in Europe as summer time starts
The race is on to turn your body into a GLP-1 factory












